Emily I Chen

Title: Innovations by Emily I Chen

Introduction

Emily I Chen is a notable inventor based in Port Jefferson, NY (US). She has made significant contributions to the field of biochemistry, particularly in the development of plasminogen receptors and their associated antibodies. With a total of two patents to her name, her work has implications for various physiological and pathophysiological processes.

Latest Patents

Emily's latest patents include innovations related to plasminogen receptors. The first patent focuses on the C9orf46 homolog, a novel murine membrane protein, and its human and mouse orthologs, termed Plg-R. This invention details the isolation method and the function of this molecule, which binds to plasminogen and its fragments, including angiostatin. The patent highlights the role of plasminogen receptors in modulating cell surface proteolysis and processes such as inflammation, tissue remodeling, wound healing, and tumor cell invasion. The second patent also pertains to the C9orf46 homolog and its function, emphasizing the modulation of apoptosis and cell death through the use of antibodies that inhibit plasminogen binding to Plg-R.

Career Highlights

Emily I Chen has established herself as a prominent figure in her field through her innovative research and patent contributions. Her work has garnered attention for its potential applications in medical science, particularly in understanding and treating conditions related to cell migration and apoptosis.

Collaborations

Emily has collaborated with notable colleagues, including Lindsey A Miles and John B Yates. These partnerships have likely contributed to the depth and breadth of her research, enhancing the impact of her inventions.

Conclusion

Emily I Chen's contributions to the field of biochemistry through her patents on plasminogen receptors demonstrate her innovative spirit and dedication to advancing scientific knowledge. Her work continues to influence research and applications in various medical fields.